Purchase Order 75F40123P00007
Award Date
1/12/23
Potential Completion Date
3/5/24
Potential Value
$605K
Federal Agency
Food and Drug Administration
Awardee
Molecular Devices LLC
Ultimate Awardee
Danaher Corporation
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Jose, CA 95134, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a $287,976.64 firm fixed price purchase order to Molecular Devices, LLC for a BLI Detection System. As a prime contractor, Molecular Devices will deliver the requested detection system to support HHS FDA programs. Performance will occur at Molecular Devices' San Jose, California location from March 2020 through August 2020. No set aside designation or subcontractors were indicated. The award provides the...
The Department of Health and Human Services Food and Drug Administration awarded a firm-fixed price purchase order contract worth $249,210.00 to Molecular Devices LLC, a subsidiary of Danaher Corporation, for an ImageXpress Micro 4 High Content Screening System. The system is intended to enable the FDA's National Center for Toxicological Research to perform measurements of intracellular calcium flux in human-induced pluripotent stem cell-derived cardiomyocytes to better understand the mechanisms...
This is a $190,019.00 firm fixed-price purchase order awarded by the U.S. Food and Drug Administration (FDA) and Center for Food Safety and Applied Nutrition (CFSAN) to Molecular Devices LLC, a subsidiary of Danaher Corporation. The contract is for an on-site preventative maintenance service agreement for Molecular Devices' Image-Xpress Confocal HT.AI high-content screening system. The contract has an ultimate completion date of September 29, 2027. Molecular Devices is a for-profit limited...
This firm fixed price purchase order from the Department of Health and Human Services' Food and Drug Administration (HHS FDA) to Molecular Devices LLC is valued at seventy-three thousand three hundred seventy-four dollars ($73,374) to upgrade an existing ImageXpress Micro Confocal High Content Imaging System (IXMC). The upgrade will include an automated water immersion unit and a 40x Apo LWD 1.15 NA water immersion objective, as requested in the combined synopsis and solicitation to meet the...
This firm-fixed-price purchase order was awarded by the Food and Drug Administration (FDA) to Molecular Devices LLC, a division of Danaher Corporation, to procure a SpectraMax iD3 multi-mode microplate reader. The $24,994.92 contract will replace an existing, non-functioning instrument due to software/operating system incompatibilities. Molecular Devices is a leading provider of bioanalytical measurement solutions and has received numerous prime federal contracts from agencies like the NIH,...
This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Molecular Devices LLC, a subsidiary of Danaher Corporation. The contract is for the provision of a microplate reader and accessories with a ceiling value of $23,350.77. The contract has an ultimate completion date of November 14, 2014. Molecular Devices LLC is a for-profit limited liability company that specializes in advanced bioanalytical measurement solutions and has a strong presence in...
The National Institutes of Health's National Center for Advancing Translational Sciences awarded a $3.86 million firm fixed price purchase order to Molecular Devices LLC for the acquisition of five Molecular Devices ImageXpress Confocal High-Content Imaging Systems, one FLIPR Penta high-throughput cellular screening system, along with associated software, services, consumables, installation, training, customization, maintenance, and technical support. The products and services are to support the...
This purchase order awards Molecular Devices LLC $293,764 to upgrade a Molecular Devices ImageXpress System for the National Center for Advancing Translational Sciences at the National Institutes of Health. The solicitation sought proposals for a high-performance 7 line laser light source, asynchronous dispense software, installation, and operational training to support the system. As the sole anticipated awardee and brand name equipment provider, Molecular Devices will deliver the requested...
This is a firm-fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Molecular Devices LLC, a division of Danaher Corporation, for preventative maintenance and unlimited repair services on a Molecular Devices ImageXpress Micro Confocal (IXMC) High Content Imaging System. The contract has a base period of one year and four one-year option periods, with a ceiling value of $219,315.88 if all options are exercised. The contract was competitively awarded, with no...
Molecular Devices LLC has been awarded a $28,203.20 firm fixed price purchase order by the Centers for Disease Control and Prevention (CDC) for laboratory equipment. As the prime contractor, Molecular Devices will provide unspecified lab equipment to the CDC in support of its disease prevention and public health missions. No set-aside designation was used for this procurement. Performance will take place in San Jose, California by September 30, 2023. Molecular Devices is a for-profit...